Short Title:
ESA Clin Immune Studies
Responsible HRP Element:
Human Health Countermeasures
Funding Status:
Completed - Task completed and produced a deliverable
|
Procurement Mechanism(s):
|
|
Aims:
1. Assessment and understanding of immune system changes associated with specific adverse clinical events. 2. Assessment and understanding of latent virus reactivation associated with specific adverse clinical events.
Integration/Unique Aspects: collaboration with ESA for sample specific aspects.
Category:
Risk Characterization, Quantification
Subcategory:
Evidence or Risk Characterization
Description:
This study will provide a report of clinical immune data for ICU stress/sepsis patients. This study is currently underway in Munich, Germany. This study assesses cytokine profiles and herpes virus reaction using Intensive Care Unit stay as a stress model. Upon completion, Gap closure will be ~15%.
Internal Customers:
Human Health Countermeasures
External Customers:
None